Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-191 passage
• A systematic review and Bayesian network meta-analysis of risk of intracranial hemorrhage with direct oral anticoagulants1 passage
• An International Survey on the Assessment of Screening and Treatment of Thrombosis Complications in Pediatrics (ASTRO-Kids): communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis1 passage
• Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH1 passage
• Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis1 passage
• Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis1 passage
• Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasis on vascular endothelium-related biomarkers in disseminated intravascular coagulation1 passage
• Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis1 passage
• D-dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta-analysis1 passage
• Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials1 passage
• Direct oral anticoagulants after bariatric surgery-What is the evidence?1 passage
• Effect of oral anticoagulants on hemostatic and thromboembolic complications in hip fracture: A systematic review and meta-analysis1 passage
• Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children: A systematic review1 passage
• Evidence-based risk stratification of patients with acute pulmonary embolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease1 passage
• Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study1 passage
• Glucagon-like peptide 1 receptor agonists and risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trials1 passage
• How to monitor and manage unfractionated heparin in practice (Part 1)? Guidance from the SSC of the ISTH1 passage
• Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial1 passage
• Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study1 passage
• Management of anticoagulation in patients with heparin-induced thrombocytopenia requiring cardiac surgery with cardiopulmonary bypass: guidance from the ISTH SSC on Perioperative and Critical Care Haemostasis and Thrombosis1 passage
• Mortality, diagnosis, and etiology of disseminated intravascular coagulation-a systematic review and meta-analysis: communication from the ISTH SSC subcommittee on disseminated intravascular coagulation1 passage
• Perceived relative clinical significance of the risks of venous thromboembolism and bleeding from pharmacologic thromboprophylaxis in children: an international survey of pediatric providers: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis1 passage
• Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial1 passage
• Perioperative management of direct oral anticoagulants in patients having a high-bleed-risk surgery or neuraxial procedure: the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE)-2 pilot randomized trial1 passage
• Postthrombotic syndrome-related chronic limb pain in children: findings from the Multicenter Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial1 passage
• Predictive performance of the CHA2DS2-VASc rule in atrial fibrillation: a systematic review and meta-analysis1 passage
• Rate of abnormal uterine bleeding in women on anticoagulation for venous thromboembolism: systematic review and meta-analysis1 passage
• Recombinant human DNase-I improves acute respiratory distress syndrome via neutrophil extracellular trap degradation1 passage
• Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation1 passage
• Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data1 passage
• Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH1 passage
• Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review1 passage
• Standardization of Platelet Activation Tests for the Diagnosis of Heparin-Induced Thrombocytopenia: Communication from the ISTH-SSC Subcommittee on Immune-Mediated Platelet Disorders1 passage
• Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibility1 passage
• The effect of fibrinogen concentrate on perioperative bleeding in transurethral resection of the prostate: a double-blind placebo-controlled and randomized study1 passage